Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study

2020 ◽  
Vol 29 (6) ◽  
pp. 485-491 ◽  
Author(s):  
Theddeus Iheanacho ◽  
Kevin Payne ◽  
Jack Tsai
Keyword(s):  
Feasibility Study ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Community Based ◽  
Mobile Community ◽  
Pilot Feasibility Study ◽  
Buprenorphine Treatment

Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder

2021 ◽  
Author(s):  
Alene Kennedy-Hendricks ◽  
Cameron J. Schilling ◽  
Alisa B. Busch ◽  
Elizabeth A. Stuart ◽  
Haiden A. Huskamp ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Health Plans ◽  
Opioid Use ◽  
Buprenorphine Treatment

scholarly journals Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal

2007 ◽  
Vol 6 (1) ◽  
Author(s):  
Jean Louis A Ndiaye ◽  
Roger C Tine ◽  
Babacar Faye ◽  
El Hadj Lamine Dieye ◽  
Pape Amadou Diack ◽  
...  
Keyword(s):  
Health Care ◽  
Feasibility Study ◽  
Community Based ◽  
Pilot Feasibility Study

scholarly journals Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes

2021 ◽  
pp. 1-9
Author(s):  
James B. Anderson ◽  
Stephen A. Martin ◽  
Anne Gadomski ◽  
Nicole Krupa ◽  
Daniel Mullin ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Outcomes ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Project Echo ◽  
Buprenorphine Treatment

scholarly journals Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder

2021 ◽  
Vol 12 ◽  
Author(s):  
Annabelle M. Belcher ◽  
Kelly Coble ◽  
Thomas O. Cole ◽  
Christopher J. Welsh ◽  
Anna Whitney ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Community Treatment ◽  
Successful Implementation ◽  
Opioid Use ◽  
Screening Process ◽  
Detention Center ◽  
Medication Prescription ◽  
Proven Efficacy ◽  
Pass Through ◽  
Buprenorphine Treatment

Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings—a gap that could be addressed using telemedicine. Here we describe a new program of telemedicine-based clinical provision of new/continuing buprenorphine treatment for individuals detained in a rural jail. Implementation objectives were completed between January and August 2020, and patient encounters were conducted between August 2020 and February 2021. We established (i) telemedicine hardware/software capability; (ii) a screening process; (iii) buprenorphine administration methods; (iv) necessary medical release procedures; (v) telemedicine encounter coordination and medication prescription procedures; and (vi) a research platform. Seven incarcerated patients have been treated, two of whom were referred from community treatment. Patients were mostly male (71%), non-Hispanic White (86%), and averaged 33 years old. All patients tested positive for an opioid upon intake and began/continued buprenorphine treatment in the jail. Average time to first MOUD appointment was 9 days and patients were maintained in treatment an average 21 days. Referrals for continuing community treatment were offered to all patients prior to discharge. We report successful implementation of telemedicine MOUD in a rural detention center, with treatment engagement and initiation occurring prior to the high-risk period of discharge. The fact that this program was launched during the height of the pandemic highlights the flexibility of telemedicine-based buprenorphine treatment. Challenges and obstacles to implementation of buprenorphine treatment in a correctional system are discussed.

scholarly journals Implementing a Low-threshold Audio-only Telehealth Model for Medication-assisted Treatment of Opioid Use Disorder at a Community-based Non-profit Organization in Washington, D.C.

2021 ◽  
Author(s):  
Ellis Jaewon Yeo ◽  
Hannah Kralles ◽  
David Sternberg ◽  
Dana McCullough ◽  
Ajetha Nadanasabesan ◽  
...  
Keyword(s):  
Patient Characteristics ◽  
The United States ◽  
Opioid Use Disorder ◽  
Retention Rates ◽  
People Who Use Drugs ◽  
Opioid Use ◽  
Treatment Access ◽  
Community Based ◽  
Medication Assisted Treatment ◽  
Low Threshold

Abstract BackgroundThe COVID-19 pandemic has had especially devastating effects on people who use drugs. Due to pandemic protocols in the United States, medication-assisted treatment (MAT) regulations became more flexible, permitting our community-based nonprofit organization to transition its low-threshold MAT clinic to an audio-only telehealth model of care in 2020. Case PresentationThis case study describes our transition from a low-threshold community-based in-person MAT clinic to an audio-only telehealth model. We extracted data from electronic health records to describe patient characteristics and to calculate treatment retention rates. We measure the success of our intervention relative to published retention rates, both overall as well as for in-person and telehealth care. ConclusionsLow-threshold medication-assisted treatment in the care of people with opioid use disorder is essential to increasing treatment access and continuity. We found that an audio-only telehealth model was viable. Although we had decreased retention rates following the transition to an audio-only telehealth model, our rates remained excellent compared to published values for in-person MAT care. We call for advocacy and regulations to support continued use of telehealth services throughout and beyond the COVID-19 pandemic.

scholarly journals Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Walter Ling ◽  
Vijay R. Nadipelli ◽  
Arnie P. Aldridge ◽  
Naoko A. Ronquest ◽  
Caitlyn T. Solem ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Opioid Use ◽  
Long Acting ◽  
Buprenorphine Treatment

scholarly journals Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults

2020 ◽  
Vol 208 ◽  
pp. 107879 ◽  
Author(s):  
Kelly R. Peck ◽  
Taylor A. Ochalek ◽  
Gary J. Badger ◽  
Stacey C. Sigmon
Keyword(s):  
Emerging Adults ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Buprenorphine Treatment
Sign in / Sign up

Export Citation Format

Share Document